查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514034

全球预测诊断市场

Predictive Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 276 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球预测诊断市场预计将达到 53 亿美元

全球预测诊断市场预计 2023 年为 26 亿美元，预计到 2030 年将达到 53 亿美元，2023 年至 2030 年复合年增长率为 10.4%。

美国市场预估为7.353亿美元，中国预期复合年增长率为9.7%

预计 2023 年美国预测诊断市场规模将达 7.353 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到8.048亿美元，2023-2030年分析期间复合年增长率为9.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 9.3% 和 8.6%。在欧洲，德国的复合年增长率预计约为 8.4%。

全球预测诊断市场－主要趋势与驱动因素总结

预防性医疗保健正在经历从反应性医学向预防性医学的转变，重点是早期发现和预防，以在健康风险发展为更严重的情况之前对其进行管理。这种积极主动的方法包括定期检查、免疫接种和教育工作，以培养更健康的人口。特别是，预防性检查已成为现代医疗保健的重要组成部分，提供早期预警并防止严重的健康损害。例如，在印度，家庭诊断测试迅速普及，尤其是对于 II 型糖尿病等疾病，早期发现可以预防心臟衰竭等併发症。同样，早期癌症筛检，例如子宫颈癌的 HPV 检测和定期乳癌筛检，可以显着提高存活率。这些预防措施不仅可以改善健康状况，还可以透过最大限度地减少广泛治疗和住院治疗的需要来减轻经济负担。

技术进步使预防保健更加有效和广泛。人工智慧 (AI) 和机器学习 (ML) 正在提高诊断准确性，并能够及早发现心臟病和阿兹海默症疾病。美国食品药物管理局(FDA) 讚扬了基于人工智慧的诊断工具在识别癌症方面的准确性，强调了它们改善医疗保健服务的潜力，特别是在资源有限的环境中。此外，医疗保健组织越来越多地透过预测分析来利用大量资料，利用机器学习和高级分析来获取洞察，从而提高业务效率和患者照护。这种方法有助于疾病预防和管理，透过预测疾病进展和促进早期疗育改善患者的治疗结果。物联网 (IoT) 技术透过即时监控患者健康状况并及时进行医疗干预以防止病情恶化，进一步增强了这一点。

儘管有这些好处，但预测诊断和早期检测技术的采用在确定需求、向患者宣传其好处以及确保这些创新的财务和监管支持方面面临着挑战​​。为了解决这些障碍，医疗保健组织必须进行彻底的市场研究，建立策略伙伴关係，并投资研发。智慧财产权保护以及将新技术融入现有医疗保健系统对于扩大预防性医疗保健的范围也至关重要。预测诊断的广泛采用预示着一场以预防和早期疗育为重点的医疗保健革命。这种方法不仅旨在降低医疗保健成本，而且还提高生活质量，并为全球医疗保健系统的弹性未来奠定基础。

受访企业范例（共47家）

  • Abbott Molecular
  • Almac Group Ltd.
  • Ambry Genetics Corp.
  • BioGenex
  • Epistem Ltd.
  • Epistem Ltd.
  • MDxHEALTH Inc.
  • Myriad Genetics Inc.
  • OPKO Health, Inc.
  • Prometheus Laboratories Inc.
  • QIAGEN NV

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP-7843

Global Predictive Diagnostics Market to Reach US$5.3 Billion by 2030

The global market for Predictive Diagnostics estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$735.3 Million While China is Forecast to Grow at 9.7% CAGR

The Predictive Diagnostics market in the U.S. is estimated at US$735.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$804.8 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Predictive Diagnostics Market - Key Trends and Drivers Summarized

Preventive healthcare is experiencing a transformative shift from reactive to proactive medical practices, emphasizing early detection and prevention to manage health risks before they develop into more severe conditions. This proactive approach includes regular screenings, vaccinations, and educational outreach, aimed at fostering a healthier population. Preventive screenings, in particular, have become an integral part of modern healthcare, offering early warnings and preventing serious health outcomes. For instance, in India, the popularity of home-diagnostic tests is surging, particularly for conditions like Type II diabetes where early detection can prevent complications such as heart failure. Similarly, early cancer screenings, like HPV tests for cervical cancer and routine checks for breast cancer, have significantly improved survival rates. These preventive measures not only lead to better health outcomes but also reduce the economic burden by minimizing the need for extensive treatments and hospitalizations.

Technological advancements are making preventive care more efficient and widespread. Artificial intelligence (AI) and machine learning (ML) are enhancing diagnostic accuracy, enabling earlier detection of diseases such as heart conditions and Alzheimer’s. The FDA has recognized AI-based diagnostic tools for their precision in identifying cancer, which highlights their potential to improve healthcare delivery, especially in resource-limited environments. Additionally, healthcare organizations are increasingly leveraging vast data pools through predictive analytics, which utilizes ML and advanced analytics to extract insights that enhance operational efficiency and patient care. This approach helps in disease prevention and management, improving patient outcomes by predicting disease progression and facilitating early intervention. The Internet of Things (IoT) technology further augments this by allowing real-time monitoring of patient health, enabling timely medical interventions that prevent conditions from worsening, thus reducing hospital visits and enhancing overall patient outcomes.

Despite the benefits, the adoption of predictive diagnostics and early detection technologies faces challenges such as establishing demand, educating patients on the benefits, and securing financial and regulatory support for these innovations. To address these obstacles, healthcare organizations need to conduct thorough market research, form strategic partnerships, and invest in research and development. Protecting intellectual property and integrating new technologies into existing healthcare systems are also vital for expanding the scope of preventive healthcare. The broader adoption of predictive diagnostics heralds a major transformation in healthcare, focusing on prevention and early intervention. This approach not only aims to reduce healthcare costs but also enhances the quality of life, setting a foundation for a resilient future in global healthcare systems.

Select Competitors (Total 47 Featured) -

  • Abbott Molecular
  • Almac Group Ltd.
  • Ambry Genetics Corp.
  • BioGenex
  • Epistem Ltd.
  • Epistem Ltd.
  • MDxHEALTH Inc.
  • Myriad Genetics Inc.
  • OPKO Health, Inc.
  • Prometheus Laboratories Inc.
  • QIAGEN N.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Predictive Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in AI and Machine Learning Propel Growth in Predictive Diagnostics
    • Increasing Healthcare Data Availability Expands Addressable Market Opportunity
    • Rising Incidence of Chronic Diseases Throws the Spotlight on Predictive Diagnostics
    • Growing Emphasis on Preventive Healthcare Generates Demand for Predictive Solutions
    • Integration with Electronic Health Records (EHR) Spurs Adoption
    • Personalized Medicine Trends Sustain Growth in Predictive Diagnostic Tools
    • Big Data Analytics Advances Propel Growth in Predictive Healthcare Solutions
    • Cloud Computing Innovations Expand Addressable Market for Predictive Diagnostics
    • Improved Patient Outcomes through Early Detection Strengthens Business Case for Predictive Diagnostics
    • AI-driven Predictive Models Generate Demand for Advanced Diagnostic Tools
    • Real-time Monitoring and Predictive Analytics Propel Growth in Patient Care Management
    • Innovations in Biomarker Discovery Generate Opportunities for Predictive Diagnostics
    • Integration with IoT Devices in Healthcare Propels Growth of Predictive Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Predictive Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Rest of Europe Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Asia-Pacific Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF WORLD
    • TABLE 28: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of World Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION